世界の腫瘍におけるコンパニオン診断検査市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Companion Diagnostic Tests in Oncology Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1500 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、腫瘍におけるコンパニオン診断検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（タンパク質検出、DNA検出）、用途別市場規模（製薬・バイオテクノロジー企業、医療機器企業、研究機関、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腫瘍におけるコンパニオン診断検査の市場動向 ・企業の競争状況、市場シェア ・腫瘍におけるコンパニオン診断検査の種類別市場規模（タンパク質検出、DNA検出） ・腫瘍におけるコンパニオン診断検査の用途別市場規模（製薬・バイオテクノロジー企業、医療機器企業、研究機関、その他） ・腫瘍におけるコンパニオン診断検査の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍におけるコンパニオン診断検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍におけるコンパニオン診断検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍におけるコンパニオン診断検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍におけるコンパニオン診断検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Roche、Genomic Health、QIAGEN、Agilent、Agendia、BioMerieux、Illumina、Siemens Healthcare、Thermo Fisher） ・結論

Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.

Market Analysis and Insights: Global Companion Diagnostic Tests in Oncology Market
The global Companion Diagnostic Tests in Oncology market size is projected to reach US$ 6938.9 million by 2026, from US$ 3644.4 million in 2019, at a CAGR of 9.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostic Tests in Oncology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Diagnostic Tests in Oncology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Diagnostic Tests in Oncology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Diagnostic Tests in Oncology market.

Global Companion Diagnostic Tests in Oncology Scope and Market Size
Companion Diagnostic Tests in Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Companion Diagnostic Tests in Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Protein Detection
DNA Detection

Segment by Application
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Protein Detection
1.2.3 DNA Detection
1.3 Market by Application
1.3.1 Global Companion Diagnostic Tests in Oncology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Medical Device Companies
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Companion Diagnostic Tests in Oncology Market Perspective (2016-2027)
2.2 Companion Diagnostic Tests in Oncology Growth Trends by Regions
2.2.1 Companion Diagnostic Tests in Oncology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Companion Diagnostic Tests in Oncology Historic Market Share by Regions (2016-2021)
2.2.3 Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2022-2027)
2.3 Companion Diagnostic Tests in Oncology Industry Dynamic
2.3.1 Companion Diagnostic Tests in Oncology Market Trends
2.3.2 Companion Diagnostic Tests in Oncology Market Drivers
2.3.3 Companion Diagnostic Tests in Oncology Market Challenges
2.3.4 Companion Diagnostic Tests in Oncology Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue
3.1.1 Global Top Companion Diagnostic Tests in Oncology Players by Revenue (2016-2021)
3.1.2 Global Companion Diagnostic Tests in Oncology Revenue Market Share by Players (2016-2021)
3.2 Global Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Companion Diagnostic Tests in Oncology Revenue
3.4 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio
3.4.1 Global Companion Diagnostic Tests in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Tests in Oncology Revenue in 2020
3.5 Companion Diagnostic Tests in Oncology Key Players Head office and Area Served
3.6 Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
3.7 Date of Enter into Companion Diagnostic Tests in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Tests in Oncology Breakdown Data by Type
4.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Type (2016-2021)
4.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Tests in Oncology Breakdown Data by Application
5.1 Global Companion Diagnostic Tests in Oncology Historic Market Size by Application (2016-2021)
5.2 Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Companion Diagnostic Tests in Oncology Market Size (2016-2027)
6.2 North America Companion Diagnostic Tests in Oncology Market Size by Type
6.2.1 North America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)
6.2.2 North America Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027)
6.2.3 North America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2027)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Application
6.3.1 North America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)
6.3.2 North America Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027)
6.3.3 North America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2027)
6.4 North America Companion Diagnostic Tests in Oncology Market Size by Country
6.4.1 North America Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021)
6.4.2 North America Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Companion Diagnostic Tests in Oncology Market Size (2016-2027)
7.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type
7.2.1 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)
7.2.2 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027)
7.2.3 Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2027)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application
7.3.1 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)
7.3.2 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027)
7.3.3 Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2027)
7.4 Europe Companion Diagnostic Tests in Oncology Market Size by Country
7.4.1 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021)
7.4.2 Europe Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size (2016-2027)
8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type
8.2.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2016-2027)
8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application
8.3.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2016-2027)
8.4 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region
8.4.1 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Companion Diagnostic Tests in Oncology Market Size (2016-2027)
9.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Type
9.2.1 Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)
9.2.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027)
9.2.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2027)
9.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Application
9.3.1 Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)
9.3.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027)
9.3.3 Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2027)
9.4 Latin America Companion Diagnostic Tests in Oncology Market Size by Country
9.4.1 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021)
9.4.2 Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size (2016-2027)
10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type
10.2.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2016-2027)
10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application
10.3.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2016-2027)
10.4 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country
10.4.1 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Companion Diagnostic Tests in Oncology Introduction
11.1.4 Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Companion Diagnostic Tests in Oncology Introduction
11.2.4 Roche Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.2.5 Roche Recent Development
11.3 Genomic Health
11.3.1 Genomic Health Company Details
11.3.2 Genomic Health Business Overview
11.3.3 Genomic Health Companion Diagnostic Tests in Oncology Introduction
11.3.4 Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.3.5 Genomic Health Recent Development
11.4 QIAGEN
11.4.1 QIAGEN Company Details
11.4.2 QIAGEN Business Overview
11.4.3 QIAGEN Companion Diagnostic Tests in Oncology Introduction
11.4.4 QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.4.5 QIAGEN Recent Development
11.5 Agilent
11.5.1 Agilent Company Details
11.5.2 Agilent Business Overview
11.5.3 Agilent Companion Diagnostic Tests in Oncology Introduction
11.5.4 Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.5.5 Agilent Recent Development
11.6 Agendia
11.6.1 Agendia Company Details
11.6.2 Agendia Business Overview
11.6.3 Agendia Companion Diagnostic Tests in Oncology Introduction
11.6.4 Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.6.5 Agendia Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux Companion Diagnostic Tests in Oncology Introduction
11.7.4 BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.7.5 BioMerieux Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Companion Diagnostic Tests in Oncology Introduction
11.8.4 Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.8.5 Illumina Recent Development
11.9 Siemens Healthcare
11.9.1 Siemens Healthcare Company Details
11.9.2 Siemens Healthcare Business Overview
11.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Introduction
11.9.4 Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.9.5 Siemens Healthcare Recent Development
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Details
11.10.2 Thermo Fisher Business Overview
11.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Introduction
11.10.4 Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021)
11.10.5 Thermo Fisher Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Companion Diagnostic Tests in Oncology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Protein Detection
Table 3. Key Players of DNA Detection
Table 4. Global Companion Diagnostic Tests in Oncology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Companion Diagnostic Tests in Oncology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Companion Diagnostic Tests in Oncology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2016-2021)
Table 8. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2022-2027)
Table 10. Companion Diagnostic Tests in Oncology Market Trends
Table 11. Companion Diagnostic Tests in Oncology Market Drivers
Table 12. Companion Diagnostic Tests in Oncology Market Challenges
Table 13. Companion Diagnostic Tests in Oncology Market Restraints
Table 14. Global Companion Diagnostic Tests in Oncology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Companion Diagnostic Tests in Oncology Market Share by Players (2016-2021)
Table 16. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2020)
Table 17. Ranking of Global Top Companion Diagnostic Tests in Oncology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Tests in Oncology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Companion Diagnostic Tests in Oncology Product Solution and Service
Table 21. Date of Enter into Companion Diagnostic Tests in Oncology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2016-2021)
Table 25. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Companion Diagnostic Tests in Oncology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2016-2021)
Table 29. Global Companion Diagnostic Tests in Oncology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Company Details
Table 62. Abbott Business Overview
Table 63. Abbott Companion Diagnostic Tests in Oncology Product
Table 64. Abbott Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Roche Company Details
Table 67. Roche Business Overview
Table 68. Roche Companion Diagnostic Tests in Oncology Product
Table 69. Roche Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 70. Roche Recent Development
Table 71. Genomic Health Company Details
Table 72. Genomic Health Business Overview
Table 73. Genomic Health Companion Diagnostic Tests in Oncology Product
Table 74. Genomic Health Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 75. Genomic Health Recent Development
Table 76. QIAGEN Company Details
Table 77. QIAGEN Business Overview
Table 78. QIAGEN Companion Diagnostic Tests in Oncology Product
Table 79. QIAGEN Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 80. QIAGEN Recent Development
Table 81. Agilent Company Details
Table 82. Agilent Business Overview
Table 83. Agilent Companion Diagnostic Tests in Oncology Product
Table 84. Agilent Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 85. Agilent Recent Development
Table 86. Agendia Company Details
Table 87. Agendia Business Overview
Table 88. Agendia Companion Diagnostic Tests in Oncology Product
Table 89. Agendia Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 90. Agendia Recent Development
Table 91. BioMerieux Company Details
Table 92. BioMerieux Business Overview
Table 93. BioMerieux Companion Diagnostic Tests in Oncology Product
Table 94. BioMerieux Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 95. BioMerieux Recent Development
Table 96. Illumina Company Details
Table 97. Illumina Business Overview
Table 98. Illumina Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 99. Illumina Recent Development
Table 100. Siemens Healthcare Company Details
Table 101. Siemens Healthcare Business Overview
Table 102. Siemens Healthcare Companion Diagnostic Tests in Oncology Product
Table 103. Siemens Healthcare Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 104. Siemens Healthcare Recent Development
Table 105. Thermo Fisher Company Details
Table 106. Thermo Fisher Business Overview
Table 107. Thermo Fisher Companion Diagnostic Tests in Oncology Product
Table 108. Thermo Fisher Revenue in Companion Diagnostic Tests in Oncology Business (2016-2021) & (US$ Million)
Table 109. Thermo Fisher Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Diagnostic Tests in Oncology Market Share by Type: 2020 VS 2027
Figure 2. Protein Detection Features
Figure 3. DNA Detection Features
Figure 4. Global Companion Diagnostic Tests in Oncology Market Share by Application: 2020 VS 2027
Figure 5. Pharmaceutical & Biotechnology Companies Case Studies
Figure 6. Medical Device Companies Case Studies
Figure 7. Research Institutes Case Studies
Figure 8. Others Case Studies
Figure 9. Companion Diagnostic Tests in Oncology Report Years Considered
Figure 10. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Companion Diagnostic Tests in Oncology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Companion Diagnostic Tests in Oncology Market Share by Regions: 2020 VS 2027
Figure 13. Global Companion Diagnostic Tests in Oncology Market Share by Regions (2022-2027)
Figure 14. Global Companion Diagnostic Tests in Oncology Market Share by Players in 2020
Figure 15. Global Top Companion Diagnostic Tests in Oncology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic Tests in Oncology as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Companion Diagnostic Tests in Oncology Revenue in 2020
Figure 17. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2016-2021)
Figure 18. Global Companion Diagnostic Tests in Oncology Revenue Market Share by Type (2022-2027)
Figure 19. North America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Companion Diagnostic Tests in Oncology Market Share by Type (2016-2027)
Figure 21. North America Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
Figure 22. North America Companion Diagnostic Tests in Oncology Market Share by Country (2016-2027)
Figure 23. United States Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Companion Diagnostic Tests in Oncology Market Share by Type (2016-2027)
Figure 27. Europe Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
Figure 28. Europe Companion Diagnostic Tests in Oncology Market Share by Country (2016-2027)
Figure 29. Germany Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Companion Diagnostic Tests in Oncology Market Share by Region (2016-2027)
Figure 39. China Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Companion Diagnostic Tests in Oncology Market Share by Type (2016-2027)
Figure 47. Latin America Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
Figure 48. Latin America Companion Diagnostic Tests in Oncology Market Share by Country (2016-2027)
Figure 49. Mexico Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Companion Diagnostic Tests in Oncology Market Share by Country (2016-2027)
Figure 55. Turkey Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Companion Diagnostic Tests in Oncology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Abbott Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 59. Roche Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 60. Genomic Health Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 61. QIAGEN Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 62. Agilent Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 63. Agendia Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 64. BioMerieux Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 65. Illumina Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 66. Siemens Healthcare Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 67. Thermo Fisher Revenue Growth Rate in Companion Diagnostic Tests in Oncology Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---